Evaxion Biotech (NASDAQ: EVAX) announced Q3 2024 financial results and business updates. Key highlights include...
Business
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over...
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Financial Analytics Market by Component, Application, Deployment Model, Enterprise Size, End-user -...
A business plan outlines your business’s financial goals and explains how you’ll achieve them over the next three to five...
ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Welcome back to Haul of Fame, your must-read beauty roundup for new products, new ideas and an intriguing argument for...
